https://www.ncbi.nlm.nih.gov/gene/7432
VIP vasoactive intestinal peptide [Homo sapiens (human)] - Gene - NCBI
vasoactive intestinal peptidehomo sapienshuman genevipncbi
https://www.semanticscholar.org/topic/Vasoactive-Intestinal-Peptide/13078
Vasoactive Intestinal Peptide | Semantic Scholar
A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular,...
vasoactive intestinal peptidesemanticscholar
https://www.scirp.org/journal/paperinformation?paperid=7567
Vasoactive Intestinal Peptide (VIP) and VIP Receptors-Elucidation of Structure and Function for...
Vasoactive intestinal peptide (VIP) is a 28-amino acid polypeptide first isolated from swine duodenum. VIP is a neurotransmitter that is extensively...
vasoactive intestinal peptidestructure functionvip
https://pmc.ncbi.nlm.nih.gov/articles/PMC7789055/
Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by...
Ulcerative colitis (UC) is a chronic relapsed intestinal disease with an increasing incidence around the world. The pathophysiology of UC remains unclear....
vasoactive intestinal peptideresearch advances
https://www.semanticscholar.org/topic/Vasoactive-intestinal-peptide-stain/12298229
Vasoactive intestinal peptide Ag:PrThr:Pt:Tiss:Ord:Immune stain | Semantic Scholar
vasoactive intestinal peptide
https://pmc.ncbi.nlm.nih.gov/articles/PMC6092975/
The Anti-Inflammatory Mediator, Vasoactive Intestinal Peptide, Modulates the Differentiation and...
Genetic background, epigenetic modifications, and environmental factors trigger autoimmune response in rheumatoid arthritis (RA). Several pathogenic infections...
vasoactive intestinal peptideanti inflammatorymediatordifferentiation
https://www.ncbi.nlm.nih.gov/protein/2RRI_A
Chain A, Vasoactive intestinal peptide - Protein - NCBI
vasoactive intestinal peptidechainproteinncbi
https://pmc.ncbi.nlm.nih.gov/articles/PMC3090995/
Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review - PMC
There is mounting evidence that pulmonary arterial hypertension (PAH), asthma and chronic obstructive pulmonary disease (COPD) share important pathological...
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.984198/full
Frontiers | Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2...
Owing to the increasing prevalence of type 2 diabetes, the development of novel hypoglycemic drugs has become a research hotspot, with the ultimate goal of d...